|
|
Life Sciences
No End In Sight In Plavix Battle
Monday, August 21, 2006
Attorneys spent a second day in court Monday arguing over whether Apotex’ generic version of the blockbuster blood thinner Plavix should be allowed on the market. |
Federal Circuit Overturns Jury Verdict Against ACell
Monday, August 21, 2006
The Federal Circuit has overturned a jury verdict that found biotechnology company ACell Inc. liable for patent infringement of a tissue-engineering method for healing wounds and scars, ruling against Cook Biotech Inc. and Purdue Research Foundation. |
DexCom Scores Stay, Partial Dismissal In Abbott Suit
Friday, August 18, 2006
DexCom Inc. revealed Friday that it received a favorable ruling in a patent infringement dispute with rival Abbott Diabetes Care Inc. over technology related to glucose monitors used by diabetics. |
Gloves Come Off In Plavix Battle
Friday, August 18, 2006
Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement. |
In Gleevec Feud, Novartis Targets Indian Patent Rules
Friday, August 18, 2006
In its ongoing battle to patent its cancer treatment Gleevec in India, Novartis AG has lashed out not only at the rejection of its patent application earlier this year, but at a key section of India’s recently enacted patent laws. |
Jury Bats Down Synthon’s Claim Against Pfizer
Friday, August 18, 2006
In another victory for brand name drug companies, a federal jury has rejected Dutch generics maker Synthon IP Inc.’s claim that Pfizer Inc.’s blockbuster blood pressure drug Norvasc violates its intellectual property. |
Ranbaxy Bids For Second Look In Lipitor Feud
Thursday, August 17, 2006
Swiping back in the battle over Pfizer Inc.’s Lipitor, Indian drug maker Ranbaxy Laboratories Ltd. on Wednesday asked a U.S. appeals court to reconsider part of a ruling that would block a generic version of the cholesterol medicine from hitting the market until 2010. |
Trial Slated For Monday In Wyeth Hormone Drug Case
Thursday, August 17, 2006
The first of thousands of personal injury lawsuits against Wyeth over the company’s hormone therapy drugs, which were used to treat the symptoms of menopause, is slated to begin on Monday. |
Bristol-Myers, Sanofi Try To Cope With Generic Plavix
Wednesday, August 16, 2006
In an attempt to cope with Apotex Inc.’s recent launch of generic Plavix, Bristol-Myers Squibb Co. and Sanofi-Aventis SA are offering the buyers of Plavix prices below the price of the generic version. |
In HIV/AIDS Fight, Tough Choices Loom For Thailand
Wednesday, August 16, 2006
Weeks after protestors rallied against British drug maker GlaxoSmithKline’s efforts to patent an anti-retroviral in Thailand, the World Bank warned in a report Wednesday that the country must decide whether to shell out market prices for patented drugs as a rising number of Thais living with HIV/AIDS are forced to turn to so-called second-line drugs. |
ZymoGenetics Punches Bristol-Myers With Suit
Tuesday, August 15, 2006
Drug developer ZymoGenetics Inc. has hit Bristol-Myers Squibb Co. with a lawsuit, accusing the pharmaceutical giant of infringing on its patented fusion protein technology. |
Shire, Barr Resolve Suits Over Generic Adderall
Tuesday, August 15, 2006
Shire PLC and Barr Pharmaceuticals have made amends in a long-running patent stand-off over Barr’s efforts to market a copycat version of Shire’s blockbuster hyperactivity drug Adderall. |
Abbott Slashes HIV Drug Price For Developing Nations
Tuesday, August 15, 2006
Still struggling with how to protect its patent rights, drug maker Abbott Laboratories Inc. has said it will launch new initiatives aimed at expanding the availability of its new HIV medicine in the developing world. |
Merck And Teva May Forgo Trial Over Actonel
Monday, August 14, 2006
The latest round in Merck & Co.’s long-running patent battle with generics maker Teva over bone strengthening compounds may end with a whimper rather than a bang, after both sides reportedly dropped their plans to go to trial. |
Novartis Challenges Gleevec Patent Block In India
Monday, August 14, 2006
Less than a year after India’s Patent Controller denied Novartis AG's patent application for the cancer treatment Gleevec, the Swiss-based pharmaceutical company is railing against the rejection. |
Sanofi, Bristol-Myers Fire Back In Plavix Feud
Monday, August 14, 2006
Hot on the heels of Apotex’ launch of an at-risk generic version of Plavix earlier this month, Sanofi-Aventis and Bristol-Myers Squibb are lashing out at the generic drug maker, filing a motion for a preliminary injunction on Monday in an attempt to block Apotex’ copycat version of the blood thinner. |
Digene To Pay $3.5M Over 13 Months In License Pact
Friday, August 11, 2006
Medical company Digene Corp. announced on Thursday that it will make nonrefundable sublicense payments totaling $3.5 million to Abbott Laboratories over the next 13 months for patents relating to human vitro diagnostics. |
Solvay Sues Canada Co. Over ANDA For Generic Aceon
Friday, August 11, 2006
Determined to keep its hypertension treatment Aceon out of the hands of generic pharmaceutical makers, Solvay Pharmaceuticals Inc. has brought a suit against a Canada-based company known for aggressively pursuing generic versions of brand-name drugs. |
Patent Suits Entangle Clinical Trial Tech. Industry
Wednesday, August 09, 2006
A full-throttle patent infringement campaign in the health care software industry is underway in New England, where a company called Datasci LLC has topped off a recent victory with a slew of new lawsuits. |
Sanofi Sues To Protect Lovenox
Wednesday, August 09, 2006
Two subsidiaries of French drug giant Sanofi-Aventis have filed a federal patent infringement lawsuit to stave off generic competition for the popular anti-clotting drug Lovenox. |
 |
French Tax Raises Money For Drugs—And IP Concerns
As international governments and drug companies struggle to find a balance between protection of intellectual property and the rights of poor nations to access crucial medications, a controversial new French initiative stands to fuel the growing debate by pressuring the pharmaceutical industry to lower its prices. |
|
Latest Articles
London Fog Lets Go Of Trademark
Monday, August 21, 2006
Still selling off its assets, bankrupt rainwear maker London Fog Group Inc. has unloaded its famed trademark, with Iconix Brand Group Inc. snapping up the recognizable brand for $30.5 million in cash and $7 million in stock.
|
No End In Sight In Plavix Battle
Monday, August 21, 2006
Attorneys spent a second day in court Monday arguing over whether Apotex’ generic version of the blockbuster blood thinner Plavix should be allowed on the market.
|
Lengthy Patent Battle Wages On For Microsoft
Monday, August 21, 2006
Timeline Inc. announced Monday that it has terminated a limited license with Microsoft Corp. for use of its patents with the software giant’s SQL Servers, and has asked a federal court to add Microsoft to a patent infringement lawsuit.
|
eBay Opinion Doesn’t Affect Preliminary Injunctions, Judge Rules
Monday, August 21, 2006
A federal judge has ruled that a landmark Supreme Court decision involving eBay only relates to permanent injunctions and not preliminary ones.
|
Federal Circuit Overturns Jury Verdict Against ACell
Monday, August 21, 2006
The Federal Circuit has overturned a jury verdict that found biotechnology company ACell Inc. liable for patent infringement of a tissue-engineering method for healing wounds and scars, ruling against Cook Biotech Inc. and Purdue Research Foundation.
|
Silicon Graphics To Retain Paul Hastings
Monday, August 21, 2006
Silicon Graphics Inc. has requested permission to hire Paul, Hastings, Janofsky & Walker LLP to act as its special intellectual property counsel.
|
Courts Write History on Permanent Injunctions In Patent Actions
Monday, August 21, 2006
Although a few more pages have been filled on the subject, there are still more pages that need to be written before the full impact and proper manner of applying the logic set forth in eBay will be understood, say Anthony F. Lo Cicero and Charles R. Macedo of Amster, Rothstein & Ebenstein LLP.
|
DexCom Scores Stay, Partial Dismissal In Abbott Suit
Friday, August 18, 2006
DexCom Inc. revealed Friday that it received a favorable ruling in a patent infringement dispute with rival Abbott Diabetes Care Inc. over technology related to glucose monitors used by diabetics.
|
EchoStar Wins Block Of Damaging DVR Injunction
Friday, August 18, 2006
The U.S. Courts of Appeals for the Federal Circuit Friday blocked a temporary injunction that would have prevented Echostar Communication Corp. from selling some of its digitial video recorders and stopped the service of about 4 million DVRs within 30 days.
|
Gloves Come Off In Plavix Battle
Friday, August 18, 2006
Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.
|
|
|
